Concepedia

Alison Holcroft

AH

Statistics

Publications

3

Citations

76

H-Index

3

Active since

2014

Affiliations

University of Liverpool(Current)

Alison Holcroft is an author at University of Liverpool specializing in molecular oncology, oncology, and molecular biology.

Publications per year

2014–2018

3

Publications

3

Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients

Claire Lucas, Robert J. Harris, Alison Holcroft et al. · Leukemia · 2015 · 39 citations · Full text

, , +12

CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML

Claire Lucas, Laura J. Scott, Natasha Carmell et al. · Blood Advances · 2018 · 22 citations · Full text

, , +11

Evidence that the pregnane <scp>X</scp> and retinoid receptors <scp>PXR</scp>,<scp> RAR</scp> and <scp>RXR</scp> may regulate transcription of the transporter <i>h<scp>OCT</scp>1</i> in chronic myeloid leukaemia cells

Gemma Austin, Alison Holcroft, Natasha Rinne et al. · European Journal Of Haematology · 2014 · 15 citations

, , +17

1–3 of 3